We tend to admire people who achieve difficult things through determination, sweat, and effort. Someone who spends years dieting, resisting cravings, and losing weight is often praised for their discipline. But what happens when another person achieves a similar result with the aid of medication? Does the achievement become less meaningful because it required less effort?
I find this question particularly interesting in the context of GLP-1 medications. Much of the discussion around semaglutide and tirzepatide has focused on their effectiveness, safety, and cost. These are important considerations, but they do not fully explain why people can have such different reactions to its use. Some regard medication as a sensible way to improve their health. Others are uncomfortable with the idea of relying on it, even when they recognise its potential benefits.
Psychological Barriers to Medication Use
It would be easy to attribute these differences to concerns about side effects or distrust of pharmaceutical interventions. Both matter, as research on attitudes toward anti-obesity medication suggests (Le Roux et al., 2025). Yet I think there is another psychological question worth examining: How much of our sense of achievement depends on believing that we accomplished something through our own effort?
Consider what self-control typically means in everyday life. We associate it with resisting temptation, suppressing desires, and making difficult choices. Someone who wants a slice of cake but decides against it is exercising restraint. We admire that restraint because we recognise the internal conflict involved.
GLP-1 medications complicate this understanding. Research involving semaglutide suggests that treatment can influence food cravings and certain eating-related experiences (Wharton et al., 2023). If someone experiences fewer cravings, the psychological demands of managing their eating may also change. They might not need to resist temptation to the same extent because the temptation itself has become less prominent.
I think of this as motivational quieting. By this, I mean a reduction in how frequently or intensely a desire captures someone’s attention. It is a conceptual distinction rather than an established clinical measure, but one that may help us understand the psychological experience of appetite regulation.
Effort vs. Absence of Desire: Different Experiences of Behavioral Change
What interests me is the difference between successfully resisting a desire and no longer experiencing that desire as strongly in the first place. Both can contribute to behavioural change, but they involve different experiences of effort.
And this is where questions about identity become relevant. If someone has spent years believing that successful weight management requires discipline and sacrifice, medication may challenge that belief. They may welcome the relief while simultaneously questioning how much credit they can take for the outcome. This reaction is not necessarily irrational. People attach meaning to the processes through which they achieve their goals, not merely to the results. However, problems arise when effort becomes a moral standard against which we judge other people’s health decisions.
Research on obesity stigma has repeatedly shown how beliefs about personal responsibility influence attitudes towards weight (Ringel & Ditto, 2019; Westbury et al., 2023). Beames et al. (2016) also examined how perceived effort shapes evaluations of weight loss. These findings raise an uncomfortable question: Why are we sometimes more impressed by the suffering involved in achieving a result than by the result itself?
The emergence of GLP-1 medications makes this question difficult to ignore. People who use pharmaceutical assistance can be judged differently from those who achieve weight loss through diet and exercise (Sprengholz et al., 2026). Such judgements may reveal less about the person taking medication than about our cultural expectations surrounding discipline and deservingness.
Is Less Effort Less Admirable?
Choosing not to use a GLP-1 medication does not automatically indicate a concern about identity or self-control. People have legitimate reasons for declining treatment, including side effects, medical circumstances, affordability and personal preferences. These considerations should not be reduced to psychological resistance, nor should anyone feel morally obliged to accept medication.
Still, I suspect that our reactions to GLP-1 medications tell us something important about the way we define personal agency. We often assume that having control means being able to resist what we want. But perhaps control can also involve choosing circumstances or interventions that make certain desires easier to manage.
This leaves me with a question that extends well beyond weight management: If two people reach the same goal, but one experiences considerably less struggle along the way, why are we so quick to treat the harder journey as the more admirable one?
